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ABSTRACT 24 
Published medical research influences healthcare providers and policy makers, guides patient 25 
management, and is based on the peer review process. Peer review should prevent publication 26 
of unreliable data and improve study reporting, but there is little evidence that these aims are 27 
fully achieved. In the blinded systems, authors and readers do not know the reviewers’ 28 
identity. Moreover, the reviewers’ reports are not made available to readers. Anonymous peer 29 
review poses an ethical imbalance toward authors, who are judged by masked referees, and to 30 
the medical community and society at large, in case patients suffer the consequences of 31 
acceptance of flawed manuscripts or erroneous rejection of important findings. Some general 32 
medical journals have adopted an open process, require reviewers to sign their reports, and 33 
links online prepublication histories to accepted articles. This system increases editors’ and 34 
reviewers’ accountability and allows public scrutiny, consenting readers understand on which 35 
basis were decisions taken and by whom. Moreover, this gives credit to reviewers for their 36 
apparently thankless job, as online availability of signed and scored reports may contribute to 37 
researchers’ academic curricula. However, the transition from the blind to the open system 38 
could pose problems to journals. Reviewers may be more difficult to find, and publishers or 39 
medical societies could resist changes that may affect editorial costs and journals’ revenues. 40 
Nonetheless, also considering the risk of competing interests in the medical field, general and 41 
major specialty journals could consider testing the effects of open review on manuscripts 42 
regarding studies that may influence clinical practice. 43 
44 
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INTRODUCTION. PEER REVIEW: THE BASE OF EVIDENCE-BASED MEDICINE 45 
Medical journals disseminate scientific information that helps understanding, preventing, and 46 
treating diseases. Editors decide which data will be available to the medical community and to 47 
patients also based on reports of experts in the field who, acting as consultants, verify if 48 
research findings meet the necessary standards. Although editors retain the authority and 49 
responsibility to override reviewers' recommendations regarding the final disposition of 50 
manuscripts, reviewers appear to be influential, and it has been reported that in two top-tier 51 
specialty journals a recommendation for rejection or acceptance was eventually accompanied 52 
by, respectively, 93% rejection and 67% acceptance rates [1]. Therefore, peer reviewers play 53 
a crucial role in the selection of those studies that, once published, will inform health care 54 
decisions.  55 
 Through the years, the peer review system has undergone increasing enquiry and 56 
criticisms, mainly due to the possibility of bias, conscious or unintentional (see, as reviews on 57 
the different types of bias, [2-4]) and the considerable effects they can have on the scientific 58 
literature that will eventually inform health care decisions [5].  Moreover, when the peer 59 
review process fails, there are additional negative consequences, as scientists who got 60 
published without deserving it, or scientists who got rejected despite deserving to be 61 
published, respectively gain or lose credits incorrectly, and this has an indirect impact on 62 
reputation and grants. This causes distortions in the mechanisms through which science self-63 
regulate itself also in terms of resource allocation, and has an indirect effect on the value of 64 
knowledge produced by the system. 65 
 Modifications of the process have been studied with the goal of improving the quality 66 
of reviewers' evaluations and, consequently, that of reports of biomedical studies and of the 67 
evidence offered to health care providers, policy makers, and consumers [2,3,6-8]. In 68 
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particular, some medical journals have adopted an open peer review system, thus revealing 69 
the reviewers' identity to authors [9], whereas reviewers are usually kept anonymous (blind or 70 
closed peer review). Given the critical importance of peer review and the potential effect of 71 
any editorial decision, recommendations have been made to assess the feasibility of a 72 
transition from the blind to the open system also within specialty journals [10,11]. Some 73 
advantages and disadvantages of open versus blind pre-publication peer review are here 74 
examined.  75 
METHODS 76 
 The best quality evidence was selected with preference given to the most recent and 77 
definitive original articles and reviews. Information was identified by searches of MEDLINE 78 
and references from relevant articles, using combinations of MESH terms “peer review”, 79 
“blind peer review”, “open peer review” “medical publishing”, and “conflict of interest". The 80 
search was limited to peer-reviewed, full-text articles in the English language. Papers 81 
published in the last 20 years were considered. Open pre-publication review (e.g., as adopted 82 
by PeerJ) and post-publication review (e.g., as adopted by F1000Research) will not be 83 
addressed owing to lack of adequate evaluation in the medical field. 84 
BLIND PEER REVIEW: THE DARK SIDE OF SCIENCE? 85 
In theory, single-blind peer review (reviewers know the authors' identity whereas reviewers 86 
are kept anonymous to authors) should allow unconditioned judgments without concerns 87 
regarding potential consequences on one's career and personal relationships [12]. This system 88 
would protect especially young researchers assessing manuscripts submitted by senior or 89 
academically powerful investigators [13]. However, this closed model is not immune from 90 
systematic bias, as reviewers may not limit themselves to an objective evaluation of research 91 
methodology and findings' validity, but may interpret the study according to personal 92 
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convictions or friendship/enmity with authors [9, 14]. This may occur frequently in 93 
subspecialty fields, where most experts know each other well. The possibility for authors to 94 
suggest/exclude reviewers could hypothetically further complicate the issue, but no 95 
differences in quality of reports were observed when reviewers were suggested by authors or 96 
by editors [15].  97 
 To prevent bias, double-blind peer review (reviewers and authors do not know each 98 
other’s identity) has been studied or implemented by some general and specialty journals [16-99 
18]. Nonetheless, interested authors can make themselves easily recognizable [19]. Therefore, 100 
to achieve adequate blinding, the entire manuscript should be accurately de-identified before 101 
sending it out for review, thus imposing a burdensome and costly extra-work to editorial 102 
offices. In spite of these efforts, reviewers are still able to identify authors in up to 40% of 103 
instances [20]. Independently of the preference expressed by both authors and reviewers, [21] 104 
double-blind peer review was not associated with better quality reports compared with single-105 
blind peer review [22-24]. In particular, neither blinding reviewers to authors’ identity and 106 
provenience of the manuscript, nor asking them to sign their reports, improved the errors’ 107 
detection rate [17]. Moreover, knowledge of authors and origin of data might be considered 108 
important [3].  109 
 Finally, neither system prevents the risk of intellectual plagiarism, attempts at delaying 110 
manuscript publication, or the influence of financial conflicts of interest (COI). Reviewers 111 
must disclose COIs, but it is not always clear if this leads to their exclusion in case of relevant 112 
financial ties. For a subspecialty or small journal, finding competent and available reviewers 113 
already may be difficult, and selecting only those without financial and non-financial COIs 114 
might be impracticable. 115 
PROS AND CONS OF OPEN PRE-PUBLICATION PEER REVIEW 116 
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Junior reviewers who have to sign reports on manuscripts written by powerful academicians 117 
may refrain from negative judgments because of fear of unfavorable consequences on their 118 
career [13]. Senior peers may fear revenges in case of future reversal of roles in manuscript 119 
evaluation [12]. Conversely, a sort of reciprocal favoritism may ensue, with a "credit" to be 120 
cashed when the reviewer will in turn submit a manuscript indicating the author's name 121 
among the suggested reviewers. In other words, once everything is public, scientists could 122 
even rationally start to game the system. For instance, considering peer review as a 123 
cooperation dilemma, scientists can reciprocate favorable reviews to known reviewers who 124 
previously ensured positive reviews to them, and sanction those ones who did not. This can 125 
increase evaluation bias [25].  As mentioned before, this may happen also with reviewers’ 126 
recommendations. However, the fact that studies did not fully capture this effect is due to 127 
sample bias, as scientists could play sophisticated reciprocity strategies across different 128 
journals, and this is hardly empirically traceable through data on single journals. The above 129 
risks may be higher in a specialty field where experts in specific areas of research are limited. 130 
Moreover, specialty journals may face increasing difficulties in finding available reviewers 131 
[26]. According to Khan [13], one expert out of four already declines the invitation to review 132 
by a specialty journal adopting the single-blind system, but this percentage could increase up 133 
to 40% in case of open review. In addition to inconveniences for the editorial office, 134 
excessive reviewers' self-selection may lead to a further systematic (and undetectable) bias. 135 
 In short, there could be a trade-off between full transparency and quality of the 136 
process. According to its detractors, open review may thus result in worse reports compared 137 
to blind review, but this has not been observed in randomized, controlled trials [10,11, 27]. 138 
Noteworthy, a similar study conducted by a specialty journal observed a small difference in 139 
the quality of reports in favor of open reviewers [28]. This lack of major differences has been 140 
ascribed to the Hawthorne effect, as reviewers allocated to both signed and unsigned groups 141 
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could have performed better than usual just because they knew they were participating in a 142 
trial [10, 28]. However, no such effect was apparent when a group of anonymous reviewers 143 
unaware they have been recruited in a study was included [27]. A slight improvement in the 144 
quality of reviewers' reports has been observed also in a recent retrospective study comparing 145 
open and single-blind peer review in two very similar specialty journals [29]. Moreover, 146 
reports of inappropriate or rancorous authors' reactions following an unfavorable open review 147 
are exceedingly rare [11], although unblinding reviewers in specialty/subspecialty journals 148 
may reveal less safe compared with large general medicine journals. 149 
 Proponents of open review maintain that masking reviewers identity generates an 150 
ethical imbalance, as it is improper to undergo an evaluation by anonymous judges when they 151 
know who the "defendants" are [10]. Because a completely closed system (with only an 152 
editorial assistant knowing the authors’ identity and only the editor knowing the reviewers' 153 
identity) is impractical, open peer review would be the only ethically sound option [30]. Open 154 
review has been already adopted not only by general medical journals such as The BMJ, BMJ 155 
Open, and the Journal of the Royal Society of Medicine, but also by specialty journals, 156 
including those within the BMC series. 157 
 In addition to requesting reviewers to sign their reports, some journals now make the 158 
entire pre-publication history of accepted manuscripts available online [31]. Thus, the 159 
scientific community, and not only authors, may read the reviewers' and editors’ comments, 160 
the authors’ response and the original and revised versions of the manuscript. The advantages 161 
of such a policy are multiple, and include accountability of reviewers. Owing to reputational 162 
costs, the risk of favorable judgments of methodologically flawed studied or provision of 163 
shallow reviews should be reduced [32]. Reviewers' reports could be publicly evaluable in 164 
order to verify if methodological shortcomings were correctly identified and if the suggested 165 
modifications were appropriate or unwise. Moreover, posting of pre-publication histories, 166 
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increases also editors' accountability for their choice of reviewers, and decisions regarding 167 
manuscripts [6, 30, 32].   168 
 Peer reviewing papers is one of the scientists' most important tasks, for which they are 169 
not paid and rarely get credit. An open review system linking reviews to published papers 170 
would give credit to peers undertaking a job which implies opportunity costs, but no obvious 171 
recognition [6, 30, 32]. Pre-publication reviews are usually discarded after articles are 172 
published. Sometimes this means that time, expertise, efforts, valuable content and insight are 173 
wasted [33]. Posting reviews could allow Internet access through common search engines 174 
[30]. Signed reports could help build the reviewer’s reputation and curriculum, especially if 175 
standard evaluative instruments are systematically used [34,35] and scores shown, and might 176 
constitute a teaching and training modality for junior reviewers and scientists [10]. In 177 
addition, if reviews are publicly accessible, the theoretical risk of retaliations by vengeful 178 
authors would be counterbalanced by the appreciation of a multitude of colleagues who could 179 
influence one's career as much as enemies [32].  180 
 Indeed, some initiatives have been recently undertaken with the objective of crediting 181 
reviewers. In 2012 Publons [36], an academic networking platform based in New Zealand 182 
was launched. Publons enables authors to post their reviews on the platform. Contributions 183 
are assigned Digital Object Identifiers (DOI), thus allowing the best reviewers to track and 184 
record their reviews for potential inclusion in their curricula [37]. Of note, following the 185 
recent integration of Publons with Altmetrics, a new scoring system was developed with the 186 
aim of increasing exposure to social networks and to measure alternative impact of the 187 
reviews [38-40]. Pre-val is another emerging tool gaining traction in the peer review world. 188 
Pre-val, a program working to facilitate transparency and integrity of peer review, has been 189 
recently backed by the American Association for the Advancement of Science [41]. 190 
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 Also a scholarly publisher recently explored a new modality to facilitate transparency 191 
of the peer review process and to give credit to reviewers. Elsevier launched a pilot trial 192 
publishing peer review reports as articles [42]. For five participating journals, selected 193 
reviews of accepted articles appear next to their published articles, with a separate DOI, on 194 
ScienceDirect [43]. However, editors of participating journals “can” choose to have review 195 
reports published, and, although the review reports are freely accessible to all [44], reviewers 196 
are given the option to remain anonymous. Moreover, editors’ comments and reviewers’ 197 
comments to the editors are not included [42].  198 
 Making peer review reports citable could create an incentive for reviewers. However, 199 
this also poses a serious problem, that is, how can journals publish and credit negative reports 200 
that led to manuscript rejections? This aspect has further implications, such as inducing 201 
reviewers to express negative recommendations in case they prefer not to be exposed to the 202 
public. Finally, publishers, especially commercial ones, or scientific societies owners of 203 
journals, might be reluctant to accept changes that may increase management costs for 204 
editorial offices, and potentially affect revenues from selling of reprints and advertising [45-205 
48]. In fact, particularly in specialty fields, manuscripts regarding trials sponsored by industry 206 
might be submitted preferentially to journals with anonymous peer review rather then to those 207 
adopting an open review system with links to pre-publication history. In fact, publishers and 208 
societies might consider medical journals also as business ventures that must make profits 209 
[49,50], and anything that might threaten income, at least in the short term, could be regarded 210 
with skepticism.  211 
MEDICAL PUBLISHING, ETHICAL RESPONSIBILITY, AND THE DIFFICULT 212 
CHOICE BETWEEN OLD AND NEW MODELS 213 
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Substantial differences in the quality of reviewers' reports were not observed in the now 214 
numerous primary and secondary studies conducted on the proposed modifications of the peer 215 
review process [10,11,15,17,51-54], as methodological shortcomings and study bias often go 216 
undetected independently of the system adopted [55]. What can be obtained by reviewers 217 
seems to be associated with their knowledge, motivation, and dedication, and not with a 218 
specific peer review model. 219 
 Additional weaknesses of the closed models were recently uncovered as peer-review 220 
frauds based on auto-fabricated reports hacked the publication process [56]. Surprisingly, not 221 
only authors were involved but, occasionally, editors as well [56]. Several measures have 222 
been suggested in order to increase the overall system safety, including turning off the 223 
reviewer-recommendation option, integrating the Open Researcher and Contributor ID 224 
(ORCID) to verify reviewers’ identities, and reducing the vulnerability of the editorial 225 
software [57]. In this regard, the open-review model would further discourage these illegal 226 
practices. In fact, the possibility to timely identify fake reviewers would be increased, as 227 
personal data and institutional affiliations would undergo public scrutiny in addition to pre-228 
publication editorial check. 229 
 Beyond the above aspects and considerations, the open system with posting of 230 
prepublication histories indeed changes the overall perspective and the goal itself of peer 231 
review, as it brings under the spotlights all the editorial activities linked to article publication, 232 
overcoming the limits of an excessive focus confined to reviewers' role [4,30,45,58,59]. 233 
Publications greatly influences prescribing patterns and clinical practice. It seems ethically 234 
sound that each step that leads to publication of studies that may imply consequences for 235 
patients is rendered transparent. Editors decide which manuscripts are to be rejected outright 236 
after internal assessment and which are to be sent out for external review, they select 237 
reviewers, interpret their comments, and have the power and the responsibility to accept or 238 
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override their recommendations [4,6,59]. In a blind system, all these crucial phases are 239 
generally kept secret, and this may appear inappropriate. Moreover, much emphasis is put on 240 
authors' COIs, but also COIs of editors, associate editors, and reviewers may unduly influence 241 
the manuscript fate [4,45,47,60,61]. Furthermore, COIs may be additive, in case reviewers are 242 
chosen who share the same competing interests of editorial board members who have the 243 
power to take decisions regarding manuscripts. It has been suggested that specialty journals 244 
may be at higher risk of COIs compared with general medical journals [62]. In an open 245 
system, all COIs would undergo public scrutiny, and authors and readers could also identify 246 
COIs that reviewers failed to declare and editors are unlikely to detect [4,30].  247 
 Thus, a key aspect of a transition to an open system would be to reveal the identity, the 248 
reports, and the competing interests, if any, of all those who influenced acceptance of a 249 
manuscript to the entire medical community [4,6,31,32]. According to van Rooyen et al. [11] 250 
"for important decisions that affect us, we now expect to know who made them and how they 251 
arrived at their decision". 252 
CONCLUSION 253 
 In medicine, several costly new drugs, devices, diagnostic tools, and surgical 254 
procedures are regularly evaluated. The choice among alternatives may imply different effects 255 
on the limited financial resources of individual families or public health systems. At the same 256 
time, the first Open Payment data shows that several manufacturers of drugs or devices are 257 
among the top highest spending US companies by payment to physicians, with orthopedic 258 
surgery, internal medicine, cardiology, and psychiatry being the specialties that receive the 259 
most payments. In addition, orthopedic surgery, obstetrics and gynecology, gastroenterology, 260 
cardiology, and ophthalmology are the specialties with the highest value of shares held by 261 
physicians [63]. Therefore, especially in the above fields [26,61,64], the risk of competing 262 
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interests' influence on medical publishing [4] may constitute an additional good reason why 263 
an open review system that links the full prepublication history, including editorial and 264 
reviewers' COIs, to selected published articles, could be adopted. This seems particularly 265 
important also considering that primary research constitutes the basis for systematic reviews 266 
and meta-analyses, which in turn inform clinical practice guidelines. Open review of original 267 
trial reports and clinical education articles covering new commercial diagnostic or therapeutic 268 
products, i.e., those that could influence patient management, would also further increase trust 269 
of the medical community and society in medical journals. 270 
 271 
272 
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LEARNING POINTS 273 
• Peer reviewers play a crucial role in the selection of those studies that, once published, 274 
will inform health care decisions.  275 
• Although editors retain the authority and responsibility to override reviewers' 276 
recommendations regarding the final disposition of manuscripts, reviewers appear to 277 
be influential. 278 
• The single-blind peer review system has undergone increasing scrutiny and criticisms, 279 
mainly due to the possibility of bias and the considerable effects they can have on the 280 
scientific literature. 281 
• Modifications of the process (i.e., double-blind and open peer review) have been 282 
studied with the goal of improving the quality of reviewers' evaluations and, 283 
consequently, that of reports of biomedical studies and of the evidence offered to 284 
health care providers, policy makers, and consumers. 285 
• Substantial differences in the quality of reviewers' reports were not observed in the 286 
numerous primary and secondary studies conducted on the proposed modifications of 287 
the peer review process, as methodological shortcomings and study bias often go 288 
undetected independently of the system adopted. 289 
• Independently of theoretical pros and cons, the open system with posting of 290 
prepublication histories changes the overall perspective and the goal itself of peer 291 
review, as it brings under the spotlights all the editorial activities linked to article 292 
publication, overcoming the limits of an excessive focus confined to reviewers' role. 293 
• It seems ethically sound that each step that leads to publication of studies that may 294 
imply consequences for patients is rendered transparent. 295 
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